» Articles » PMID: 8304359

Osteopenia in Adults with Cystic Fibrosis

Overview
Journal Am J Med
Specialty General Medicine
Date 1994 Jan 1
PMID 8304359
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To examine the frequency and severity of osteopenia in adults with cystic fibrosis and the clinical variables associated with reduced bone mineral.

Patients And Methods: The bone mineral status of 22 white adults (14 women) with cystic fibrosis was compared with normative data from healthy white control subjects in a university medical center. Lumbar spine, femoral neck, and whole-body bone mineral was determined by dual energy x-ray absorptiometry and expressed as bone mineral content (g), bone mineral density (g/cm2), and bone mineral apparent density (g/cm3). Bone mass was related to age, body mass, gonadal function, pulmonary status, and glucocorticoid exposure to identify variables associated with reduced bone mineral in cystic fibrosis.

Results: Bone mineral in adults with cystic fibrosis was significantly below expected values for age and sex at all sites using all expressions of bone mass. The mean Z-score was -2.8 for the lumbar spine bone density, -2.5 for the femoral neck, and -2.0 for the whole body. Bone mineral apparent density (a term that minimizes the influence of bone dimensions) was also significantly reduced in patients at the lumbar spine (p < 0.0001) and femoral neck (p < 0.001 to p < 0.0001), indicating that the bone mineral deficit seen in adults with cystic fibrosis could not be attributed to differences in bone size. Age, weight, height, and body mass index were significantly correlated with bone mineral. Pulmonary status, glucocorticoid use, and gonadal function failed to predict bone mineral status.

Conclusions: Osteopenia and osteoporosis occur commonly in young adults with cystic fibrosis. Age and body mass are predictive of bone mineral, although the pathogenesis of this bone mineral deficit is likely multifactorial.

Citing Articles

Testosterone concentrations and associated predictors in men with cystic fibrosis: A retrospective, single-center study.

Jathal I, Wang Y, Binongo J, Cobb C, Hunt W, Khan F Am J Med Sci. 2024; 368(6):637-647.

PMID: 38997066 PMC: 11563879. DOI: 10.1016/j.amjms.2024.07.013.


External validity of machine learning-based prognostic scores for cystic fibrosis: A retrospective study using the UK and Canadian registries.

Qin Y, Alaa A, Floto A, van der Schaar M PLOS Digit Health. 2023; 2(1):e0000179.

PMID: 36812602 PMC: 9931238. DOI: 10.1371/journal.pdig.0000179.


Vasoactive intestinal peptide and cystic fibrosis transmembrane conductance regulator contribute to the transepithelial calcium transport across intestinal epithelium-like Caco-2 monolayer.

Rodrat M, Wongdee K, Teerapornpuntakit J, Thongbunchoo J, Tanramluk D, Aeimlapa R PLoS One. 2022; 17(11):e0277096.

PMID: 36399482 PMC: 9674163. DOI: 10.1371/journal.pone.0277096.


Bone Mineral Density in Cystic Fibrosis Patients with the CFTR I1234V Mutation in a Large Kindred Family Is Associated with Pancreatic Sufficiency.

Abdul Wahab A, Hammoudeh M, Allangawi M, Al-Khalaf F, Chandra P Int J Rheumatol. 2014; 2014:465395.

PMID: 25093022 PMC: 4100272. DOI: 10.1155/2014/465395.


Factors associated with low bone mineral density in patients with cystic fibrosis.

Sheikh S, Gemma S, Patel A J Bone Miner Metab. 2014; 33(2):180-5.

PMID: 24633535 DOI: 10.1007/s00774-014-0572-z.